InsidersTradesSigma
Discover the detailed record of transactions filed by Hanson Bryan C, Chairman & CEO. Director active across 2 companies, notably Zimmer Biomet Holdings, INC.. In total, 4 disclosures have been published. The latest transaction was disclosed on 13 May 2026 — Levée d'options. Regulator: SEC (Form 4). All data is free.
4 of 4 declarations
Bryan C. Hanson is the President and CEO of Zimmer Biomet Holdings, Inc. and Solventum Corp. He leads the strategic operations of these companies, ensuring their growth and profitability. His experience in the medical sector is a significant asset in achieving Zimmer Biomet's objectives.